News

Study: Seniors gaining weight at greater risk of dying than seniors already overweight

BY Michael Johnsen

COLUMBUS, Ohio — Some overweight older adults don’t need to lose weight to extend their lives, but they could risk an earlier death if they pack on more pounds. According to a nationwide Ohio State University study released Thursday, people who were slightly overweight in their 50s but kept their weight relatively stable were the most likely to survive over the next 16 years.

They had better survival rates than even normal-weight individuals whose weight increased slightly, but stayed within the normal range.

On the other hand, those who started out as very obese in their 50s and whose weight continued to increase were the most likely to die during that period.

Overall, the results suggest that about 7.2% of deaths after the age of 51 are due to weight gain among obese people, at least among the generation in this study, stated Hui Zheng, lead author of the study and assistant professor of sociology at The Ohio State University.

“You can learn more about older people’s mortality risk by looking at how their weight is changing than you can by just looking at how much they weigh at any one time,” Zheng said.

While some extra weight seemed protective in this study, Zheng cautioned that these results applied only to people over 50. His previous research, published in Social Science & Medicine, suggests that being overweight may not be helpful for younger people.

Why is being slightly overweight protective for older people?

“It is probably because the older population is more likely to get illnesses and disease, especially cancer, that cause dangerous weight loss,” he said.  “In that case, a small amount of extra weight may provide protection against nutritional and energy deficiencies, metabolic stresses, the development of wasting and frailty, and loss of muscle and bone density caused by chronic diseases.”

“Our other research suggests that the negative effect of obesity on health is greater for young people than it is for older people, so young people especially shouldn’t think that being overweight is harmless,” he said.

While slightly overweight people (BMI of 25 to 29.9) whose weight was steady had the highest survival rate, those who moved from overweight to obese (BMI 30 to 34.9) were close behind.

“This suggests that among overweight people at age 51, small weight gains do not significantly lower the probability of survival,” Zheng said.

The third highest survival rate among the six groups was normal weight individuals (BMI of 18.5 to 24.9) whose weight increased slightly, but stayed within normal range.

Next came the Class I obese (BMI of 30 to 34.9) whose weight was moving upward.

Next to last were normal weight individuals who lost weight. Although the study attempted to control for illnesses among those studied, it may be that many of these individuals dropped weight because of illness.

The most obese individuals (BMI of 35 and over) who continued to add weight had the lowest survival rate of the six groups.

There weren’t enough people who started out as overweight and obese and lost weight to include in this analysis, Zheng said.

“We can’t really evaluate the effectiveness of planned weight loss on mortality. Even in the normal-weight people in this study, there was no way to tell whether weight loss was planned,” he said.

Zheng noted that the study took into account a wide variety of demographic and socioeconomic factors that may play a role in both weight and mortality among Americans. The researchers also controlled for whether the respondents smoked, whether they had a variety of chronic illnesses and how they rated their own health. The results stood even after all of these factors were taken into account.

Younger people are less likely to get many of the diseases that afflict older adults, which is one reason extra weight is not good for them, he said.

But Zheng said the main message for everyone, including older adults, is that packing on the pounds, especially if you’re obese, can be hazardous to your health. “Continuing to put on weight can lower your life expectancy,” he said.

This new study was published online this month in the American Journal of Epidemiology


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Prestige Brands solution to pediatric overdosing — unique squeezable, single-dose APAP packet

BY Michael Johnsen

TARRYTOWN, N.Y. — Prestige Brands on Wednesday released PediaCare Single Dose Acetaminophen Fever Reducer/Pain Reliever — the only pre-measured acetaminophen in individual, squeezable packets perfect for anytime dosing, according to the company.

To help educate caregivers about the Single Dose product and offer tips on knowing when a child should be given acetaminophen, PediaCare has partnered with father and pediatrician, Dr. David Hill, author of Dad to Dad: Parenting like a Pro, to develop an informational video on the single dose product.

“Dosing instructions can be confusing for parents," Hill said. “This innovative product takes a trusted medicine and transforms it into an easy-to-use solution.”

PediaCare Single Dose contains the accurate dose for just one treatment and is available in two sizes. The 7.5 mL packet is for children 36-47 lbs. or ages 4 to 5 years, and a 10 mL packet is for children 48-59 lbs. or ages 6 to 8 years. PediaCare Single Dose is specially designed for little mouths to make taking medicine less intimidating, and the squeezable packet helps eliminate spills and creates less mess than a dosing cup. Each packet is child resistant with a fold-and-tear opening process. Caregivers then simply squeeze the medicine from the packet directly into the child’s mouth, similar to the squeezable yogurt and pureed fruit products to which most children have become accustomed.

Child safety was a driving force in the development of PediaCare Single Dose, Prestige Brands reported. Over the counter medications are involved in approximately one-third of emergency department visits among children under the age of 12. Of those visits, 80% of them are due to unsupervised children taking medications on their own and 10% of emergency department visits in this age group are due to medication errors. With only one dose included in each child-resistant packet, the threat of overdosing is greatly decreased.

PediaCare Single Dose Acetaminophen Fever Reducer/Pain Reliever will be available at major retail, mass merchandiser and drug store chains nationwide beginning September 2013.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Walgreens adopts new data-driven encounter support platform for Healthcare Clinic

BY Michael Johnsen

BOWIE, Md. — Inovalon and Walgreens on Thursday announced that they have entered into a multi-year agreement to provide Inovalon’s data-driven encounter support platform, Electronic Patient Assessment Solution Suite (ePASS) within Healthcare Clinic at select Walgreens to support improvements in managed care quality and performance.

"Through this partnership, we’ll be able to utilize the power of analytics to provide a higher level of individualized care to our patients, which will ultimately improve the patient experience and outcomes," stated Heather Helle, divisional VP, Healthcare Clinic.   

"The healthcare landscape is rapidly evolving through the material growth in membership within Medicare Advantage and managed Medicaid health plans in addition to the launch of the Health Insurance Exchange Marketplaces," added Keith Dunleavy, president and CEO of Inovalon. "Bringing advanced analytics directly to the point-of-care environment is a critical element in achieving meaningful healthcare goals. We are proud to partner with Walgreens to improve healthcare outcomes and promote healthier lifestyles for our client health plan membership populations."

Inovalon’s ePASS platform delivers analytics to the point of care, supporting the identification and resolution of gaps in quality, care, assessment, documentation and risk score accuracy. This results in improved patient outcomes, provider insight and health plan performance, the companies noted. 

Leveraging analytical insights derived from the ongoing analysis of more than 7 billion medical events within Inovalon’s Medical Outcomes Research for Effectiveness and Economics Registry, ePASS enables a focused, patient-specific encounter to achieve superior benefit and impact for the patient, provider and health plan, the companies concluded.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES